Patterson Companies, Inc. (0KGB.L)
USD 30.89
(-0.19%)
USD 30.89
(-0.19%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 762.94 Million USD | 21.49% |
| 2023 | 627.99 Million USD | 6.4% |
| 2022 | 590.23 Million USD | -18.23% |
| 2021 | 721.86 Million USD | 8.01% |
| 2020 | 668.32 Million USD | -10.81% |
| 2019 | 749.31 Million USD | -26.15% |
| 2018 | 1.01 Billion USD | -5.35% |
| 2017 | 1.07 Billion USD | 1.26% |
| 2016 | 1.05 Billion USD | 46.02% |
| 2015 | 725 Million USD | 0.0% |
| 2014 | 725 Million USD | 0.0% |
| 2013 | 725 Million USD | -14.71% |
| 2012 | 850 Million USD | 61.9% |
| 2011 | 525 Million USD | 0.0% |
| 2010 | 525 Million USD | -4.02% |
| 2009 | 547 Million USD | -16.49% |
| 2008 | 655.03 Million USD | 263.86% |
| 2007 | 180.02 Million USD | -40.0% |
| 2006 | 300.04 Million USD | -6.69% |
| 2005 | 321.55 Million USD | -35.64% |
| 2004 | 499.58 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 2.1 Million USD | -70.83% |
| 1998 | 7.2 Million USD | 140.0% |
| 1997 | 3 Million USD | -6.25% |
| 1996 | 3.2 Million USD | -3.03% |
| 1995 | 3.3 Million USD | -63.33% |
| 1994 | 9 Million USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 19.2 Million USD | -11.11% |
| 1991 | 21.6 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 894.98 Million USD | 17.68% |
| 2024 FY | 762.94 Million USD | 21.49% |
| 2024 Q1 | 664.91 Million USD | 5.88% |
| 2024 Q2 | 760.49 Million USD | 14.37% |
| 2024 Q4 | 762.94 Million USD | -14.75% |
| 2023 Q3 | 739.96 Million USD | 0.15% |
| 2023 Q4 | 627.99 Million USD | -15.13% |
| 2023 Q1 | 710.25 Million USD | 20.33% |
| 2023 FY | 627.99 Million USD | 6.4% |
| 2023 Q2 | 738.83 Million USD | 4.03% |
| 2022 Q3 | 697.28 Million USD | -1.55% |
| 2022 Q2 | 708.24 Million USD | -0.48% |
| 2022 Q1 | 711.67 Million USD | -1.41% |
| 2022 FY | 590.23 Million USD | -18.23% |
| 2022 Q4 | 590.23 Million USD | -15.35% |
| 2021 Q1 | 803.01 Million USD | 20.15% |
| 2021 Q2 | 784.93 Million USD | -2.25% |
| 2021 Q4 | 721.86 Million USD | -7.54% |
| 2021 FY | 721.86 Million USD | 8.01% |
| 2021 Q3 | 780.7 Million USD | -0.54% |
| 2020 Q2 | 748.47 Million USD | -9.99% |
| 2020 Q1 | 831.57 Million USD | 10.98% |
| 2020 Q3 | 767.41 Million USD | 2.53% |
| 2020 Q4 | 668.32 Million USD | -12.91% |
| 2020 FY | 668.32 Million USD | -10.81% |
| 2019 Q1 | 854.14 Million USD | -15.82% |
| 2019 FY | 749.31 Million USD | -26.15% |
| 2019 Q3 | 783.77 Million USD | -4.26% |
| 2019 Q4 | 749.31 Million USD | -4.4% |
| 2019 Q2 | 818.62 Million USD | -4.16% |
| 2018 Q4 | 1.01 Billion USD | -14.39% |
| 2018 Q2 | 1.09 Billion USD | -6.65% |
| 2018 Q1 | 1.17 Billion USD | 9.72% |
| 2018 FY | 1.01 Billion USD | -5.35% |
| 2018 Q3 | 1.18 Billion USD | 7.94% |
| 2017 Q1 | 1.14 Billion USD | 7.94% |
| 2017 FY | 1.07 Billion USD | 1.26% |
| 2017 Q4 | 1.07 Billion USD | -11.73% |
| 2017 Q3 | 1.21 Billion USD | 1.73% |
| 2017 Q2 | 1.19 Billion USD | 4.47% |
| 2016 Q2 | 1.13 Billion USD | -34.44% |
| 2016 Q1 | 1.72 Billion USD | 137.93% |
| 2016 FY | 1.05 Billion USD | 46.02% |
| 2016 Q4 | 1.05 Billion USD | -14.95% |
| 2016 Q3 | 1.24 Billion USD | 10.07% |
| 2015 FY | 725 Million USD | 0.0% |
| 2015 Q4 | 725 Million USD | 0.0% |
| 2015 Q1 | 725 Million USD | 0.0% |
| 2015 Q2 | 725 Million USD | 0.0% |
| 2015 Q3 | 725 Million USD | 0.0% |
| 2014 Q1 | 860 Million USD | 18.62% |
| 2014 Q2 | 860 Million USD | 0.0% |
| 2014 Q3 | 860 Million USD | 0.0% |
| 2014 FY | 725 Million USD | 0.0% |
| 2014 Q4 | 725 Million USD | -15.7% |
| 2013 Q3 | 775 Million USD | 0.0% |
| 2013 Q2 | 775 Million USD | -8.82% |
| 2013 Q1 | 850 Million USD | 0.0% |
| 2013 Q4 | 725 Million USD | -6.45% |
| 2013 FY | 725 Million USD | -14.71% |
| 2012 FY | 850 Million USD | 61.9% |
| 2012 Q3 | 850 Million USD | 55.96% |
| 2012 Q4 | 850 Million USD | 0.0% |
| 2012 Q2 | 545 Million USD | 3.81% |
| 2012 Q1 | 525 Million USD | 0.0% |
| 2011 Q1 | 525 Million USD | 0.0% |
| 2011 Q4 | 525 Million USD | 0.0% |
| 2011 Q3 | 525 Million USD | 0.0% |
| 2011 FY | 525 Million USD | 0.0% |
| 2011 Q2 | 525 Million USD | 0.0% |
| 2010 Q1 | 539 Million USD | -1.46% |
| 2010 FY | 525 Million USD | -4.02% |
| 2010 Q4 | 525 Million USD | 0.0% |
| 2010 Q3 | 525 Million USD | 0.0% |
| 2010 Q2 | 525 Million USD | -2.6% |
| 2009 Q2 | 655.33 Million USD | 0.05% |
| 2009 FY | 547 Million USD | -16.49% |
| 2009 Q3 | 588.04 Million USD | -10.27% |
| 2009 Q4 | 547 Million USD | -6.98% |
| 2009 Q1 | 655.03 Million USD | -0.0% |
| 2008 FY | 655.03 Million USD | 263.86% |
| 2008 Q1 | 180.08 Million USD | 0.03% |
| 2008 Q2 | 180.07 Million USD | -0.0% |
| 2008 Q3 | 190.1 Million USD | 5.57% |
| 2008 Q4 | 655.03 Million USD | 244.56% |
| 2007 Q4 | 180.02 Million USD | -16.28% |
| 2007 FY | 180.02 Million USD | -40.0% |
| 2007 Q1 | 295.03 Million USD | -1.67% |
| 2007 Q2 | 290.02 Million USD | -1.7% |
| 2007 Q3 | 215.02 Million USD | -25.86% |
| 2006 Q1 | 316.55 Million USD | -1.56% |
| 2006 Q2 | 311.54 Million USD | -1.58% |
| 2006 Q3 | 305.04 Million USD | -2.08% |
| 2006 Q4 | 300.04 Million USD | -1.64% |
| 2006 FY | 300.04 Million USD | -6.69% |
| 2005 Q2 | 436.57 Million USD | -11.19% |
| 2005 FY | 321.55 Million USD | -35.64% |
| 2005 Q4 | 321.55 Million USD | -25.49% |
| 2005 Q3 | 431.56 Million USD | -1.15% |
| 2005 Q1 | 491.58 Million USD | -1.6% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | 504.59 Million USD | 0.92% |
| 2004 Q4 | 499.58 Million USD | -0.99% |
| 2004 FY | 499.58 Million USD | 0.0% |
| 2004 Q2 | 500 Million USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q1 | 1.9 Million USD | -9.52% |
| 2000 Q4 | - USD | -100.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q3 | 1.8 Million USD | 0.0% |
| 2000 Q2 | 1.8 Million USD | -5.26% |
| 1999 Q1 | 6.3 Million USD | -12.5% |
| 1999 Q4 | 2.1 Million USD | -27.59% |
| 1999 FY | 2.1 Million USD | -70.83% |
| 1999 Q2 | 2.8 Million USD | -55.56% |
| 1999 Q3 | 2.9 Million USD | 3.57% |
| 1998 Q3 | 3.9 Million USD | -48.0% |
| 1998 Q4 | 7.2 Million USD | 84.62% |
| 1998 FY | 7.2 Million USD | 140.0% |
| 1998 Q1 | 3.1 Million USD | 3.33% |
| 1998 Q2 | 7.5 Million USD | 141.94% |
| 1997 FY | 3 Million USD | -6.25% |
| 1997 Q2 | 7 Million USD | 118.75% |
| 1997 Q1 | 3.2 Million USD | 0.0% |
| 1997 Q4 | 3 Million USD | -3.23% |
| 1997 Q3 | 3.1 Million USD | -55.71% |
| 1996 Q4 | 3.2 Million USD | 3.23% |
| 1996 Q1 | 3.2 Million USD | -3.03% |
| 1996 Q2 | 3.2 Million USD | 0.0% |
| 1996 Q3 | 3.1 Million USD | -3.13% |
| 1996 FY | 3.2 Million USD | -3.03% |
| 1995 Q3 | 3.2 Million USD | -5.88% |
| 1995 Q4 | 3.3 Million USD | 3.13% |
| 1995 FY | 3.3 Million USD | -63.33% |
| 1995 Q1 | 8.2 Million USD | -8.89% |
| 1995 Q2 | 3.4 Million USD | -58.54% |
| 1994 Q3 | 6.8 Million USD | -48.09% |
| 1994 Q2 | 13.1 Million USD | 0.0% |
| 1994 Q4 | 9 Million USD | 32.35% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | 9 Million USD | 0.0% |
| 1993 Q3 | 100 Thousand USD | -99.55% |
| 1993 Q4 | - USD | -100.0% |
| 1993 Q2 | 22.1 Million USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1992 Q4 | 19.2 Million USD | 0.0% |
| 1992 FY | 19.2 Million USD | -11.11% |
| 1991 FY | 21.6 Million USD | 0.0% |
| 1991 Q4 | 21.6 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -6266.853% |
| Accuray Incorporated | 172.15 Million USD | -343.168% |
| Align Technology, Inc. | 96.96 Million USD | -686.796% |
| Elevance Health Inc. | 25.12 Billion USD | 96.963% |
| AxoGen, Inc. | 69.29 Million USD | -1001.051% |
| Boston Scientific Corporation | 9.09 Billion USD | 91.613% |
| CVS Health Corporation | 79.38 Billion USD | 99.039% |
| Cardinal Health, Inc. | 5.6 Billion USD | 86.398% |
| Centene Corporation | 17.69 Billion USD | 95.689% |
| DaVita Inc. | 11.11 Billion USD | 93.137% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 98.177% |
| Hologic, Inc. | 2.53 Billion USD | 69.899% |
| Humana Inc. | 10.21 Billion USD | 92.53% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 19.511% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 87.187% |
| Masimo Corporation | 970 Million USD | 21.346% |
| McKesson Corporation | 5.47 Billion USD | 86.057% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 85.79% |
| ResMed Inc. | 873.93 Million USD | 12.701% |
| Henry Schein, Inc. | 2.74 Billion USD | 72.166% |
| Teladoc Health, Inc. | 1.59 Billion USD | 52.085% |
| Universal Health Services, Inc. | 5.36 Billion USD | 85.784% |
| Veeva Systems Inc. | 55.77 Million USD | -1267.889% |
| Baxter International Inc. | 14.36 Billion USD | 94.689% |
| Becton, Dickinson and Company | 15.87 Billion USD | 95.195% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -749.599% |
| Danaher Corporation | 19.35 Billion USD | 96.058% |
| Stryker Corporation | 12.99 Billion USD | 94.129% |
| Medtronic plc | 24.96 Billion USD | 96.944% |